Investing.com - Financial Markets Worldwide
🐂 Not all bull runs are created equal. November’s AI picks include 5 stocks up +20% eachUnlock Stocks

Dow Chemical, TeselaGen Team Up To Expand Biodesign Platform

ByZacks Investment Research
Published 08/30/2017, 08:48 AM
Updated 07/09/2023, 06:31 AM
DJI
-
DOW
-
DD
-
KRO
-
CC
-
Dow Chemical’s (NYSE:DOW) fully owned subsidiary Dow AgroSciences LLC and TeselaGen Biotechnology Inc. entered a new phase in their partnership to produce a state-of-the-art biological design automation platform that can expedite discovery work. The terms of the partnership were not divulged.
The companies collaborated in 2016 to develop a new design platform which helped scientists to increase the flow of potential discovery by ten times.
With the new phase of collaboration, the companies are building a flexible modular platform with a powerful software module that adheres to a strict design-build-test methodology for industrial-scale cloning.
Dow has outperformed the industry it belongs to over a year. The company’s shares have moved up around 19.7% over this period, compared with roughly 17.9% gain recorded by the industry.
Dow topped earnings expectations in second-quarter 2017. The company reported adjusted earnings of $1.08 per share that beat the Zacks Consensus Estimate of $1.01. The company raked in net sales of $13,834 million, up roughly 16% year over year. Sales also surpassed the Zacks Consensus Estimate of $13,655 million.
Dow is witnessing improved global economic activity with strong momentum in manufacturing, investment and trade. While strength of the consumer is driving expansion in the U.S., improvement in Europe is expected to remain on a steady track. The company is also seeing signs of stabilization in Latin America, especially in the agriculture market. Dow also believes that it is well positioned to capture demand in consumer-led markets.
The company is expected to gain from its focus on consumer-led markets and its strategic investments in the U.S. Gulf Coast and the Middle East. Dow should also benefit from its productivity management actions and cost synergies associated with Dow Corning Silicones business. The planned merger with DuPont (NYSE:DD) is also expected to create significant synergies.
Dow Chemical Company (The) Price and Consensus

Dow Chemical Company (The) Price and Consensus | Dow Chemical Company (The) Quote

Dow Chemical currently carries a Zacks Rank #3 (Hold).

Stocks to Consider

Some better-ranked companies in the chemical space include are The Chemours Company (NYSE:CC) and Kronos Worldwide (NYSE:KRO) . Both the stocks sport a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.

Chemours has an expected long-term earnings growth of 15.5%.

Kronos Worldwide has an expected long-term earnings growth of 5%.

4 Surprising Tech Stocks to Keep an Eye On

Tech stocks have been a major force behind the market’s record highs, but picking the best ones to buy can be tough. There’s a simple way to invest in the success of the entire sector. Zacks has just released a Special Report revealing one thing tech companies literally cannot function without. More importantly, it reveals 4 top stocks set to skyrocket on increasing demand for these devices. I encourage you to get the report now – before the next wave of innovations really takes off.

See Stocks Now>>



E.I. du Pont de Nemours and Company (DD): Free Stock Analysis Report

Dow Chemical Company (The) (DOW): Free Stock Analysis Report

Kronos Worldwide Inc (KRO): Free Stock Analysis Report

Chemours Company (The) (CC): Free Stock Analysis Report

Original post

Latest comments

Loading next article…
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.